Home > Press > GNS Healthcare Expands Membership at Rensselaer Polytechnic Institute: Supercomputing Center To Advance Big Data Healthcare Solutions
Leading "big data" analytics firm GNS Healthcare has signed a multi-year agreement to extend and expand its membership with the Computational Center for Nanotechnology Innovations (CCNI) at Rensselaer Polytechnic Institute. The agreement enables GNS to continue and grow its use of CCNI's massively parallel computational resources to directly support its research and operations.
GNS Healthcare Expands Membership at Rensselaer Polytechnic Institute: Supercomputing Center To Advance Big Data Healthcare Solutions
Troy, NY | Posted on June 5th, 2012
CCNI is a $100 million partnership between Rensselaer, IBM, and New York state. The center houses one of the world's most powerful university-based supercomputers and is a national leader in promoting the application of high-performance computing in industry. CCNI supports a network of more than 700 researchers in academia and industry across a diverse spectrum of disciplines.
"One of our primary goals as a public-private partnership is to support economic growth through the use of high-performance computing and we're delighted that GNS will continue to have access to the computing power it needs to innovate, grow, and move into new business areas," said CCNI Director James Myers.
"GNS has partnered with CCNI since 2007 to drive healthcare innovation through the application of GNS's supercomputer-driven REFS modeling and simulation platform using CCNI's high-performance computing. Having access to one of the world's largest supercomputing resources and working with the expert staff at CCNI for many years has allowed us to deliver results from ‘big data' that would not have been possible using solely internal computing resources. Today, the flexibility that CCNI provides as our business continues to rapidly grow enables us to seamlessly tackle our partners' biggest challenges," said Thomas A. Neyarapally, GNS Healthcare senior vice president, corporate development.
In June 2011, GNS Healthcare became one of 10 companies whose success in leveraging high-performance computing was documented through a case study developed jointly by the Council on Competitiveness and the Defense Advanced Projects Research Agency (DARPA). GNS employs its proprietary machine learning algorithms in the REFS technology platform on massively parallel supercomputers to analyze vast amounts of biomedical information, discovering new insights into the complex, clinical causes of human disease, and new opportunities for diagnosis and treatment. The company's technology has helped its collaborators improve treatment of major diseases including multiple sclerosis and cancer and reduce instances of harmful drug interactions for patients taking medicine.
"We are laser-focused on delivering value to our industrial partners and helping them achieve their strategic research goals by leveraging CCNI's expertise, software, and computing resources," Myers said. "With GNS, which itself is a provider of software and solutions to the medical and pharmaceutical communities, we act as a resource provider. They see us as a cloud —a powerful one with a supercomputer in it—that lets them concentrate on their business rather than worrying about the capital costs and complexities of running a supercomputer on their own."
CCNI opened its doors in 2007 with more than 100 teraflops of computing power, and today supports a broad range of at-scale modeling, simulation, and analysis research across a spectrum of science and engineering disciplines. The center is committed to hastening the advance of ever-shrinking computer chips and other devices that are designed and manufactured by the micro- and nanoelectronics industry and to driving the academic and industrial adoption of computationally and data-intensive techniques. Over the last five years, more than 700 researchers from 50 universities, companies, and government laboratories have run high-performance science and engineering applications at CCNI.
Last year, Rensselaer won a $2.65 million grant from the National Science Foundation (NSF) to purchase, install, and run a new balanced, green supercomputing system at CCNI designed to support the development of next-generation computational and data-intensive applications. The new system is expected to be comprised of a powerful IBM Blue Gene/Q supercomputer along with a multiterabyte memory (RAM) storage accelerator, petascale disk storage, rendering cluster, and remote display wall systems. The new system will be a national resource for academic and industrial researchers across many different disciplines.
REFS (Reverse Engineering-Forward Simulation) is comprised of integrated machine learning algorithms and software that extract causal relationships from complex, multidimensional data and enable the simulation of billions of ‘what if?' hypotheses to explore novel unseen conditions and predictions forward in time. This model-centric discovery and simulation approach represents a paradigm shift in data analysis, leapfrogging existing approaches such as high-dimensional pattern matching.
About GNS Healthcare
GNS Healthcare is a "Big Data" analytics company that has developed a scalable approach for the discovery of what works in healthcare, and for whom. GNS Healthcare's analytics solutions are being applied across the healthcare industry: from pharmaceutical and biotechnology companies, health plans and hospitals, to integrated delivery systems, Pharmacy Benefits Managers (PBMs), and Accountable Care Organizations (ACOs). Whether your organization is delivering care or developing personalized therapies and diagnostics, GNS Healthcare can help you discover the knowledge you need to match patients with treatments that work.
For more information on GNS Healthcare, visit: www.gnshealthcare.com/.
For more information, please click here
Rensselaer Polytechnic Institute
Copyright © Newswise
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Visit the Rensselaer research and discovery blog:
Follow RPI on Twitter:
Rensselaer Computational Center for Nanotechnology Innovations (CCNI):
News and information
JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
PAM-XIAMEN Offers UV LED wafer April 15th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014
First annual science week highlights STEM pipeline and partnerships: UB, SUNY Buffalo State and ECC team up with the City of Buffalo and its schools for April 7-11 events April 3rd, 2014
Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014
NanoTecNexus to Host "Chemistry of Wine" Fundraiser in Support of STEM Education - Collaborations Key to Success - March 20th, 2014
Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014
A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014
Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014
Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Peer Reviewed and Approved for Science by the the Washington Academy of Sciences April 3rd, 2014
New JEOL-Nikon MiXcroscopy Correlative Imaging Solution March 27th, 2014
Quantum Dots Take Center Stage at Inaugural Event: QD Vision Co-Founder and CTO Dr. Seth Coe-Sullivan to Chair First Quantum Dots Forum, March 26, 2014, San Diego, CA March 25th, 2014
Scalable CVD process for making 2-D molybdenum diselenide: Rice, NTU scientists unveil CVD production for coveted 2-D semiconductor April 8th, 2014
Carbon nanotubes grow in combustion flames April 1st, 2014
Never say never in the nano-world March 31st, 2014
Diamonds are an oil's best friend: Rice University leads research to find the best nanofluid for heat transfer March 31st, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
TED Selects Nanotech for Branding and Security on 30th Anniversary Conferences: Nanotech and TED collaborate to create a custom security feature using nano-imaging March 17th, 2014
Simon Fraser University Completes Installation of Electron Microscopes from FEI: SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada March 11th, 2014
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 March 3rd, 2014